Novartis AG
Process for concentration of antibodies and therapeutic products thereof
Last updated:
Abstract:
The present disclosure provides a process for concentrating proteins including an ultrafiltering, a diafiltering, and a second ultrafiltering sequence, at elevated temperatures, such as above about 30.degree. C. The disclosure also includes a process for preparing highly concentrated antibody compositions, and highly concentrated antibody products.
Status:
Grant
Type:
Utility
Filling date:
21 Apr 2014
Issue date:
6 Aug 2019